Cerebral protection devices, designed to limit the risk of stroke during transcatheter aortic valve replacement, may be especially helpful when patients undergo valve-in-valve TAVR.
Patient advocates state the updated governance would not only integrate coverage for underserved populations but also clamp down on the “games” that Medicare Advantage plans have been known to “play” with Medicaid patients.
Many public health experts believe global pandemics will become more frequent in coming years. Given the advance warning, healthcare leaders should plan now to encourage screening compliance then.
The company officially launched its Cleerly ISCHEMIA software for delivering noninvasive evaluations of CCTA exams in early 2024. This update provides a closer look at the software from a billing perspective.
Ismail El-Hamamsy, MD, PhD (left) and Carlijn Bouten, PhD, MSc (right) at the 2024 Heart Valve Society annual meeting. Image courtesy of the Heart Valve Society.
Ismail El-Hamamsy, MD, PhD, said he hopes to spend his time as HVS president focused on fostering collaborations and encouraging innovation.
The study’s authors tracked data from nearly 16,000 patients who underwent PCI from 2010 to 2023. This is believed this to be the largest comparison of intravascular imaging-guided PCI and angiography-guided PCI to date.
The veteran cardiologist had been worried that cerebral protection devices were only being used to treat TAVR patients with specific insurance plans. The lawsuit has now been resolved to the “mutual satisfaction” of both parties.
